Pharmaceutical patent term extensions (PTE) are a highly litigated area of patent law. Australia’s longest running PTE litigation relates to a patent for the antidepressant escitalopram. The latest installment in the escitalopram saga is now available, with the High Court of Australia handing down judgement in H. Lundbeck A/S v Sandoz Pty Ltd, CNS Pharma …
>> Read more
POF is proud to support International Women’s Day 2022 to collectively help #BreakTheBias in the workplace and throughout society. We acknowledged IWD by holding a morning tea across our three offices to celebrate the social, economic, cultural and political achievements of women. We were delighted to be joined by guest presenter, Madison Hartill-Law, in our …
>> Read more
A new Australian domain extension will be available from 24 March 2022, allowing eligible businesses to register .au ‘direct’ domain names for the first time. What is the new domain? The new domain extension is simply “.au” An example of a .au domain name is “pof.au”. A .au domain name is an opportunity to shorten …
>> Read more
Anyone familiar with patents in the life sciences space will be familiar with patent claims that use terminology such as “essentially”, “therapeutic agent” and “about”. The familiarity of such terms means that they are often recited without much consideration. However, their meaning was in issue in the recent decision in Pharmacia LLC v Juno Pharmaceuticals …
>> Read more
Admit it, you’ve already solved today’s wordle, right?! Around the world people have been buying into the Wordle phenomenon. For those not playing along at home, Wordle is a five letter word guessing game, which in itself is not a new concept. However, Wordle has attracted mass appeal due to the ability to share the …
>> Read more
We are delighted to announce that one of our clients, CTI BioPharma, has received FDA accelerated approval for VONJO™ (pacritinib), for the treatment of adult patients with myelofibrosis and thrombocytopenia. Pacritinib is a macrocyclic small molecule oral kinase inhibitor with activity against Janus Associated Kinase2 (JAK2), mutant JAK2V617F as well as the FMS-like tyrosine kinase 3 …
>> Read more
NFTs and Spice DAO (which stands for Decentralised Autonomous Organisation) have made the news for thinking that the laws of copyright don’t apply to the virtual realm and having their error corrected publicly by users on Twitter. Jodorowsky’s Dune Back in June 2021, POF considered the question of what a purchaser is actually acquiring when …
>> Read more
The Federal Court has recently dismissed three appeals[1] against Trade Marks Office opposition decisions relating to marks including the word “Mother”. One of these cases involved the question of a lack of intention to use the mark MOTHER LOADED ICED COFFEE in relation to inter alia, flavoured milk. Despite the fact that: the filing of …
>> Read more
The threat of patent infringement proceedings can be employed by a patentee as a very effective deterrent against those whose conduct brings them into potential conflict with their patent rights. However, such threats “can potentially cause substantial harm” and as a result may be actionable by a recipient or another person harmed by them. In …
>> Read more
A recent decision[1] of the Federal Court has confirmed the requirements for amending a patent specification to rectify a clerical error or obvious mistake and provided a timely reminder of the importance of reviewing a patent before commencing proceedings. The amendment application was made during proceedings commenced by Surefoot IP Holdings Pty Ltd (Surefoot) against …
>> Read more
